WITHDRAWN: The comparison of the effectiveness of lincocin® and azitro® in the treatment of covid-19-associated pneumonia: A prospective study
- PMID: 32543164
- DOI: 10.15586/jptcp.v27iSP1.684
WITHDRAWN: The comparison of the effectiveness of lincocin® and azitro® in the treatment of covid-19-associated pneumonia: A prospective study
Retraction in
- 10.15586/jptcp.v27iSP1.684
Abstract
For legal reasons, the publisher has withdrawn permission for online, public display of this record in PubMed. For additional information, please contact the publisher.
Keywords: COVID-19; coronavirus; medication; pneumonia; treatment.
© 2020 Journal of Population Therapeutics and Clinical Pharmacology. All rights reserved.
Conflict of interest statement
The authors declare that there is no conflict of interest.
References
-
- 1. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. - DOI
-
- 2. Wang L, Wang Y, Ye D, Liu Q. A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence. Int J Antimicrob Agents. 2020:105948. - DOI
-
- 3. Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA – J Am Med Assoc. 2020;323(13):1239–42. - DOI
-
- 4. Wan S, Xiang Y, Fang W, et al. Clinical features and treatment of COVID-19 patients in Northeast Chongqing. J Med Virol. 2020. - DOI
-
- 5. Hassan SA, Sheikh FN, Jamal S, Ezeh JK, Akhtar A. Coronavirus (COVID-19): A review of clinical features, diagnosis, and treatment. Cureus. 2020;12(3):e7355. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical